原发性肝癌患者口腔菌群多样性研究
Study on the Diversity of Oral Microflora in Patients with Primary Hepatic Carcinoma
DOI: 10.12677/ACM.2023.1351230, PDF,   
作者: 曹龙飞, 马晓莹, 许 琳*:青岛大学附属青岛市市立医院消化内科,山东 青岛
关键词: 原发性肝癌高通量核苷酸测序口腔菌群Primary Hepatic Carcinoma High-Throughput Nucleotide Sequencing Oral Microbiota
摘要: 目的:探讨口腔菌群与原发性肝癌的关系。方法:通过16S rRNA高通量测序技术分析10例原发性肝癌患者及10例健康体检者口腔菌群微生物多样性。结果:在门水平,与健康组相比肝癌组厚壁菌门丰度显著升高(P = 0.005),变形菌门丰度显著降低(P = 0.041)。在属水平,肝癌组链球菌属丰度显著升高(P = 0.023),梭杆菌属、拟普氏菌属、普氏菌属丰度显著降低(P = 0.019, P = 0.041, P = 0.028)。结论:原发性肝癌患者存在口腔菌群失调,其中链球菌属丰度显著升高,梭杆菌属、拟普氏菌属、普氏菌属丰度显著降低,能够作为生物标志物辅助原发性肝癌的早期诊断。
Abstract: Objective: To investigate the relationship between oral microflora and primary hepatic carcinoma. Methods: 16S rRNA high-throughput sequencing and bioinformatic analysis were used to examine oral bacterial diversity in the different patients including 10 patients with primary hepatic carci-noma, and 10 healthy controls. Results: At the phylum level, the proportion of Firmicutes was in-creased significantly (P = 0.005), however, the proportion of Proteobacteria was decreased signifi-cantly in L group (P = 0.041). At the genus level, the proportion of Streptococcus was increased sig-nificantly (P = 0.023), whereas the proportion of Fusobacterium, Alloprevotella and Prevotella de-creased significantly in L group (P = 0.019, P = 0.041, P = 0.028). Conclusion: The statistical analyses confirmed that there are significant differences between every two groups in one phylum and three genera, which could be used for biomarkers in diagnosis of primary hepatic carcinoma.
文章引用:曹龙飞, 马晓莹, 许琳. 原发性肝癌患者口腔菌群多样性研究[J]. 临床医学进展, 2023, 13(5): 8804-8813. https://doi.org/10.12677/ACM.2023.1351230

参考文献

[1] Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Kim, Y.S. and Shin, S.W. (2019) Hepatocellular Carcinoma. The New England Journal of Medicine, 381, e2.
[3] 徐小元, 南月敏. 原发性肝癌二级预防共识(2021年版) [J]. 临床肝胆病杂志, 2021, 37(3): 11.
[4] Pessa, M.G. (2020) Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment. Cells, 9, Article No. 1370.
[5] Samaranayake, L. Matsubara, V.H. (2017) Normal Oral Flora and the Oral Ecosystem. Dental Clinics of North America, 61, 199-215. [Google Scholar] [CrossRef] [PubMed]
[6] Brandilyn, A.P., Wu, J., Hayes, R.B., et al. (2017) The Oral Fun-gal Mycobiome: Characteristics and Relation to Periodontitis in a Pilot Study. BMC Microbiology, 17, Article No. 157. [Google Scholar] [CrossRef] [PubMed]
[7] Gopalakrishnan, V., Spencer, C.-N., Nezi, L., et al. (2018) Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients. Science, 359, 97-103. [Google Scholar] [CrossRef] [PubMed]
[8] Stachowska, E., Folwarski, M., Kaźmierczak-Siedlecka, K., et al. (2021) The Potential of Gut Microbiome as a Non-Invasive Predictive Biomarker for Early Detection of Pancreatic Can-cer and Hepatocellular Carcinoma. European Review for Medical and Pharmacological Sciences, 25, 7275-7284.
[9] Lu, H.F., et al. (2016) Deep Sequencing Reveals Microbiota Dysbiosis of Tongue Coat in Patients with Liver Carcinoma. Scientific Reports, 6, Article No. 33142.
[10] Atarashi, K., et al. (2017) Ectopic Colonization of Oral Bacteria in the Intestine Drives TH1 Cell Induction and Inflammation. Science, 358, 359-365. [Google Scholar] [CrossRef] [PubMed]
[11] Ren, Z.G., et al. (2018) Gut Microbiome Analysis as a Tool towards Targeted Non-Invasive Biomarkers for Early Hepatocellular Carcinoma. Gut, 68, 1014-1023. [Google Scholar] [CrossRef] [PubMed]
[12] Xu, X., He, J.Z., Xue, J., et al. (2015) Oral Cavity Contains Dis-tinct Niches with Dynamic Microbial Communities. Environmental Microbiology, 17, 699-710. [Google Scholar] [CrossRef] [PubMed]
[13] 杨林, 周铖, 张佳铭, 郭礼, 司海龙. 基于口-肠-肝轴理论探讨原发性肝癌的新型治疗策略[J]. 临床肝胆病杂志, 2020, 36(7): 1646-1649.
[14] 徐寅. 肝癌, 胆管癌与癌旁组织细菌的相关性研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2019.
[15] Xi, D.X., et al. (2020) Oral Microbial Com-munity Analysis of the Patients in the Progression of Liver Cancer. Microbial Pathogenesis, 149, Article ID: 104479.
[16] Shin, N.-R., Whon, T.-W. and Bae, J.-W. (2015) Proteobacteria: Microbial Signature of Dysbiosis in Gut Microbiota. Trends in Biotechnology, 33, 496-503. [Google Scholar] [CrossRef] [PubMed]
[17] Zhou, D., Pan, Q., Shen, F., et al. (2017) Total Fecal Microbiota Transplantation Alleviates High-Fat Diet-Induced Steatohepatitis in Mice via Beneficial Regulation of Gut Microbiota. Scientific Reports, 7, Article No. 1529. [Google Scholar] [CrossRef] [PubMed]
[18] De Minicis, S., Rychlicki, C., Agostinelli, L., et al. (2014) Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice. Hepatology, 59, 1738-1749. [Google Scholar] [CrossRef] [PubMed]
[19] Tett, A., Pasolli, E., et al. (2021) Prevotella Diversity, Niches and Interac-tions with the Human Host. Nature Reviews Microbiology, 19, 585-599. [Google Scholar] [CrossRef] [PubMed]
[20] Stoop, J.,-N., van der Molen, R.G., Baan, C.C., et al. (2005) Regulatory T Cells Contribute to the Impaired Immune Response in Patients with Chronic Hepatitis B Virus Infection. Hepatology, 41, 771-778. [Google Scholar] [CrossRef] [PubMed]
[21] Basic, A. and Dahlén, G. (2015) Hydrogen Sulfide Production from Sub-gingival Plaque Samples. Anaerobe, 35, 21-27. [Google Scholar] [CrossRef] [PubMed]
[22] The PLOS ONE Staff (2014) Correction: Oral Microbiota Distinguishes Acute Lymphoblastic Leukemia Pediatric Hosts from Healthy Populations. PLOS ONE, 9, e110449. [Google Scholar] [CrossRef
[23] Chen, Y.F., et al. (2011) Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis. Hepatology, 54, 562-572.
[24] Crielaard, W., Zaura, E., Schuller, A.-A., et al. (2011) Exploring the Oral Microbiota of Children at Various Developmental Stages of Their Dentition in the Rela-tion to Their Oral Health. BMC Med Genomics, 4, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
[25] Ling, Z.X., Liu, X., Cheng, Y.W., et al. (2015) Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project. Scientific Re-ports, 5, Article No. 17098. [Google Scholar] [CrossRef] [PubMed]